Matches in Nanopublications for { ?s ?p "[We conclude that anti-CD19 chimeric receptors containing 4-1BB are a powerful new tool for T-cell therapy of B-lineage ALL and other CD19+ B-lymphoid malignancies.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 7 of
7
with 100 items per page.
- NP626001.RAict0FjmA4NUJmyPQ8t2ODBAcrfDclWtWwdAqtqfEpsE130_assertion description "[We conclude that anti-CD19 chimeric receptors containing 4-1BB are a powerful new tool for T-cell therapy of B-lineage ALL and other CD19+ B-lymphoid malignancies.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP626001.RAict0FjmA4NUJmyPQ8t2ODBAcrfDclWtWwdAqtqfEpsE130_provenance.
- NP285247.RA1MUEChhnY6woF2kBrv2P7KrvT5_0pPWiDTDQpR42as4130_assertion description "[We conclude that anti-CD19 chimeric receptors containing 4-1BB are a powerful new tool for T-cell therapy of B-lineage ALL and other CD19+ B-lymphoid malignancies.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP285247.RA1MUEChhnY6woF2kBrv2P7KrvT5_0pPWiDTDQpR42as4130_provenance.
- NP416780.RAodvi1QnDP5LyGl8C9x3ThGNZqvNAAW6TATqyn67jZjg130_assertion description "[We conclude that anti-CD19 chimeric receptors containing 4-1BB are a powerful new tool for T-cell therapy of B-lineage ALL and other CD19+ B-lymphoid malignancies.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP416780.RAodvi1QnDP5LyGl8C9x3ThGNZqvNAAW6TATqyn67jZjg130_provenance.
- NP497417.RA0fjND927B1IwHRwAjkQyS2R11NAGSfE6KIt18YezZLs130_assertion description "[We conclude that anti-CD19 chimeric receptors containing 4-1BB are a powerful new tool for T-cell therapy of B-lineage ALL and other CD19+ B-lymphoid malignancies.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP497417.RA0fjND927B1IwHRwAjkQyS2R11NAGSfE6KIt18YezZLs130_provenance.
- assertion description "[We conclude that anti-CD19 chimeric receptors containing 4-1BB are a powerful new tool for T-cell therapy of B-lineage ALL and other CD19+ B-lymphoid malignancies.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP566674.RAJ9gsneh3L575qgMTfS7WmQ7kEzG8CdKI4HDisjYGn4w130_assertion description "[We conclude that anti-CD19 chimeric receptors containing 4-1BB are a powerful new tool for T-cell therapy of B-lineage ALL and other CD19+ B-lymphoid malignancies.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP566674.RAJ9gsneh3L575qgMTfS7WmQ7kEzG8CdKI4HDisjYGn4w130_provenance.
- assertion description "[We conclude that anti-CD19 chimeric receptors containing 4-1BB are a powerful new tool for T-cell therapy of B-lineage ALL and other CD19+ B-lymphoid malignancies.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.